Development of chronic renal failure in adult pure mesangial glomerulonephritis

Area of Science:

• Nephrology
• Pathology
• Internal Medicine

Background:

• Mesangial glomerulonephritis is an infrequent histopathological finding in primary glomerular diseases.
• This study focuses on pure mesangial glomerulonephritis, excluding IgA nephropathy and systemic disorders.

Purpose of the Study:

• To investigate the clinical presentation, treatment outcomes, and prognosis of pure mesangial glomerulonephritis.
• To differentiate outcomes based on the presence or absence of nephrotic syndrome.

Main Methods:

• Retrospective analysis of 64 patients with pure mesangial glomerulonephritis from 968 non-transplant renal biopsies.
• Categorization of patients into nephrotic and non-nephrotic groups.
• Review of treatment responses and long-term renal outcomes.

Main Results:

• 34.7% of patients presented with nephrotic syndrome; steroid therapy yielded low remission rates (27.3%), with 27.3% progressing to end-stage renal failure within 4-8 years.
• 65.3% presented with non-nephrotic proteinuria and erythruria; these patients generally received only anti-hypertensive treatment, with a lower rate of renal failure.
• One non-nephrotic patient died from hypertensive complications.

Conclusions:

• Pure mesangial glomerulonephritis with nephrotic syndrome has a poor prognosis despite immunosuppressive therapy.
• Non-nephrotic pure mesangial glomerulonephritis appears to have a more favorable outcome with supportive care.
• Further research is warranted to optimize treatment strategies for mesangial glomerulonephritis.